Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-18-015953
Filing Date
2018-03-08
Accepted
2018-03-08 17:27:19
Documents
1
Group Members
GILEAD THERAPEUTICS A1 UNLIMITED CO

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a18-7860_1sc13ga.htm SC 13G/A 81727
  Complete submission text file 0001104659-18-015953.txt   83207
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filed by) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GEN DE WITTELAAN L11 A3 2800 MECHELEN C9 00000
Business Address GEN DE WITTELAAN L11 A3 2800 MECHELEN C9 00000
GALAPAGOS NV (Subject) CIK: 0001421876 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-88880 | Film No.: 18677529
SIC: 2834 Pharmaceutical Preparations